611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
CDC Reverses COVID Test Guideline After ControversyAs Schools Reopen, Many Students, Staff Live With High-Risk Family MemberCOVID-19 Poses Added Risk for People With Addiction Disorders: StudyGetting a Hip Replacement? Choice of Hospital Can Be CrucialAlmost 90,000 Young American Adults Will Get Cancer This Year: ReportAnother Rapid COVID-19 Test Shows PromiseDetails Emerge on Unexplained Illness in AstraZeneca COVID Vaccine TrialRising Obesity Levels Put Americans at Risk During Pandemic: CDCMore Pets May Be Getting COVID-19 Than RealizedWildfire Smoke Poses Special Threat to People With AsthmaCOVID-19 Prevention Might Translate Into Record Low Flu Rates: CDCFor Stroke Survivors, Timely Rehab Has Been Jeopardized During PandemicCOVID-19 Has Taken a Toll on Organ DonationCOVID Conflicts Are Putting Big Strains on RelationshipsCoronavirus Vaccine Plan for Americans AnnouncedParkinson's Ups the Odds for Dangerous Falls, But Prevention Is KeyPregnant Women With COVID-19 at High Risk for ComplicationsCompanion Drug Might Help Prevent Kidney Complications of LupusAHA News: Making Sense of Cholesterol – the Good, the Bad and the DietaryDo Ordinary Eyeglasses Offer Protection Against COVID-19?Elevated Blood Clotting Factor Linked to Worse COVID-19 OutcomesParkinson's Drug Eyed as Treatment for Severe Macular DegenerationNew Drug Shows Promise in Preventing Severe COVIDSome Psoriasis Meds May Also Help Prevent Heart DiseaseSmall Study Supports Donor Plasma Therapy for Severe COVID-19Probiotic Might Help Ease Children's EczemaDeath From COVID-19 Very Rare for Americans 21 and Under: ReportEven Exercise May Not Ease Pandemic-Linked StressDoctors Should Watch for Punctured Lungs in COVID PatientsCould COVID-19 Someday Become Seasonal, Like Flu?Is Arthritis Pain Relief as Close as Your Spice Rack?Their Jobs May Put Black Americans at Greater COVID Risk'Flattening the Curve' Saves More Lives Than ThoughtFewer Kids May Be Carrying Coronavirus Without Symptoms Than Believed: StudyCOVID-19 Takes Heavy Toll on KidneysPoll Finds Pandemic Surge in Loneliness Among Older AdultsAstraZeneca COVID Vaccine Trial RestartsDonating Plasma Helps Fight Immune DisorderKids at 2 Utah Day Cares Easily Spread COVID to FamiliesCOVID Hits Young Adults Harder Than Thought: StudyAHA News: A Closer Look at COVID-19 and Heart Complications Among AthletesAt One Hospital, ICU Workers' PPE May Have Kept Coronavirus at BayBlood Pressure Meds Can Affect COVID-19 CareStudy Confirms Restaurants, Bars Are COVID Infection HotspotsHow One Hospital Kept COVID Transmissions at Nearly ZeroJust How Reliable Are COVID-19 Tests? Experts Weigh InUntreated High Blood Pressure a Growing Problem Among AmericansWest Coast Wildfires, COVID a Double Whammy to Lung HealthWho's Most Likely to Binge Eat Amid Pandemic?Colleges in 50 States Seeing COVID Cases on Campus
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

COVID-19 Is Tougher on Older Men, and Scientists May Now Know Why

HealthDay News
by By E.J. MundellHealthDay Reporter
Updated: Sep 8th 2020

new article illustration

TUESDAY, Sept. 8, 2020 (HealthDay News) -- Key differences in immune system function may help determine why severe, life-threatening COVID-19 tends to target older men, scientists say.

A new study found that among elderly people and in men, especially, certain factors may lead to a weaker immune system response against infection with SARS-CoV-2, the virus that causes COVID-19.

That could help explain high rates of intensive care unit admission and death among these patients.

"Host responses to SARS-CoV-2 are dependent on viral load and infection time, with observed differences due to age and sex that may contribute to disease severity," said a team led by Nicole Lieberman and Alexander Greninger, both of the University of Washington School of Medicine, in Seattle.

In the study, the investigators looked at bits of genetic material (RNA) collected from the nasal swabs of 430 people who tested positive for COVID-19, and another 54 who did not.

The researchers used that material to conduct a deep-dive investigation into the immune system responses of each patient following contact with the new coronavirus.

The findings showed that immune cell responses typically weren't activated until three days after infection began. Also, the strength and makeup of the immune cell response was dependent on the amount of viral load -- and responses also differed by age and sex.

For example, compared to young patients, older patients tended to have "reduced expression" of key immune system agents, which in turn may have triggered "deficiencies" in the activity of T-cells and "natural killer" (NK) cells. Both of those immune system cells are crucial in mounting a good defense against oncoming pathogens.

In addition, men seemed to show reductions in the activity of NK cells and another type of immune system cell, B-cells, compared to what was seen in women, the research team said.

Men infected with SARS-CoV-2 also showed an increase in another immunological pathway that might end in "inappropriately throttling antiviral responses," the study authors reported.

The report was published online Sept. 8 in PLOS Biology.

Reading over the new findings, infectious disease expert Dr. Amesh Adalja noted that "the clinical course of every infectious disease is a combination of viral factors, such as viral load and host immune response." Adalja is a senior scholar at the Center for Health Security at Johns Hopkins University, in Baltimore.

"This new study provides more evidence that the reason behind the elderly and males being more susceptible to severe disease from COVID has to do with differences in the host immune response," he said.

The findings might even point the way to improved treatments, Adalja added.

"By understanding the intricacies of how this dysregulated response occurs, it may become possible to modulate it with precisely targeted therapies, as well as to predict who is more likely to have a severe case," he said.

More information

The U.S. Centers for Disease Control and Prevention has more on the new coronavirus.